Record NNP B-NP O
date NN I-NP O
: : O O
2092-11-16 CD O B-DATE
Team NN B-NP O
D NNP I-NP O
Intern NNP I-NP O
Admission NNP I-NP O
Note NN I-NP O
Date NNP B-NP O
: : O O
11/16/92 CD O B-DATE
CC/HPI NNP B-NP O
: : O O
Pt NNP B-NP O
is VBZ B-VP O
76 CD B-NP B-AGE
yo NNP I-NP O
F NNP I-NP O
with IN B-PP O
h/o NN B-NP O
CAD NN I-NP O
, , O O
HTN NNP B-NP O
, , O O
hypercholesterolemia NN B-NP O
, , O O
COPD NNP B-NP O
, , O O
many JJ B-NP O
pack-years NNS I-NP O
of IN B-PP O
smoking NN B-NP O
, , O O
and CC O O
anxiety NN B-NP O
who WP B-NP O
presents VBZ B-VP O
with IN B-PP O
c/o NN B-NP O
SOB. . O O
Pt NNP B-NP O
was VBD B-VP O
in IN B-PP O
her PRP$ B-NP O
usual JJ I-NP O
state NN I-NP O
of IN B-PP O
health NN B-NP O
about IN B-PP O
1 CD B-NP O
week NN I-NP O
PTA NNP I-NP O
, , O O
when WRB B-ADVP O
she PRP B-NP O
noticed VBD B-VP O
gradually RB I-VP O
worsening VBG I-VP O
SOB JJ B-ADJP O
and CC O O
developing VBG B-VP O
cough NN B-NP O
productive JJ I-NP O
of IN B-PP O
scant JJ B-NP O
whitish JJ I-NP O
sputum NN I-NP O
. . O O
She PRP B-NP O
had VBD B-VP O
no DT B-NP O
fevers/chills NNS I-NP O
, , O O
prior RB B-ADVP O
URI NNP B-NP O
symptoms/sick NN I-NP O
contacts NNS I-NP O
, , O O
CP/lightheadedness NNP B-NP O
, , O O
N/V/abdominal JJ B-NP O
pain NN I-NP O
, , O O
diaphoresis NN B-NP O
, , O O
increasing VBG B-VP O
leg NN B-NP O
swelling VBG I-NP O
, , O O
or CC O O
orthopnea/PND NN B-NP O
symptoms NNS I-NP O
. . O O
She PRP B-NP O
thought VBD B-VP O
she PRP B-NP O
might MD B-VP O
be VB I-VP O
developing VBG I-VP O
bronchitis NN B-NP O
, , O O
discontinued VBN B-NP O
smoking NN I-NP O
and CC O O
called VBD B-VP O
her PRP B-NP O
PCP NNP O O
to TO B-VP O
ask VB I-VP O
for IN B-PP O
antibiotics NNS B-NP O
. . O O
She PRP B-NP O
was VBD B-VP O
told VBN I-VP O
to TO I-VP O
come VB I-VP O
to TO B-PP O
the DT B-NP O
clinic NN I-NP O
but CC O O
her PRP$ B-NP O
SOB NNP I-NP O
progressively RB B-VP O
worsened VBD I-VP O
in IN B-PP O
the DT B-NP O
few JJ I-NP O
hours NNS I-NP O
PTA NNP I-NP O
, , O O
and CC O O
she PRP B-NP O
called VBD B-VP O
for IN B-SBAR O
EMS NNP B-NP O
to TO B-VP O
go VB I-VP O
to TO B-PP O
the DT B-NP O
ED. NNP I-NP O
In IN B-PP O
ED NNP B-NP O
: : O O
a DT B-NP O
. . B-VP O
Lasix NNP B-NP O
40 CD I-NP O
mg NN I-NP O
IV NNP B-NP O
x2 CD I-NP O
, , O O
NTG NNP B-NP O
paste NN I-NP O
initial JJ B-NP O
SOB NNP I-NP O
improvement NN I-NP O
, , O O
small JJ B-NP O
UO NNP I-NP O
; : O O
b NN B-NP O
. . O O
Lasix NNP B-NP O
40 CD I-NP O
mg NN I-NP O
IV NNP I-NP O
x NN I-NP O
2 CD B-NP O
improved VBN B-VP O
, , O O
ready JJ B-ADJP O
for IN B-PP O
floor NN B-NP O
transfer NN I-NP O
but CC O O
develops VBZ B-VP O
an DT B-NP O
episode NN I-NP O
of IN B-PP O
worsening VBG B-VP O
SOB/flush JJ B-NP O
pulmonary JJ I-NP O
edema NN I-NP O
on IN B-PP O
CXR NNP B-NP O
; : O O
c. NN B-NP O
Lasix NNP I-NP O
160mg CD I-NP O
IV NNP I-NP O
Morphine NNP I-NP O
3mg VBZ B-VP O
IV NNP B-NP O
+ NNP I-NP O
CPAP NNP I-NP O
Atrovent/Albuterol NNP I-NP O
Zaroxylin NNP I-NP O
5mg VBZ B-VP O
+ VBN I-VP O
Lasix NNP B-NP O
200mg CD I-NP O
IV NNP I-NP O
improved VBD B-VP O
, , O O
on IN B-PP O
Hi-Flow NNP B-NP O
O2 NNP I-NP O
; : O O
total JJ B-NP O
UO NNP I-NP O
: : O O
1,100cc CD B-NP O
. . O O
Also RB B-ADVP O
received VBD B-VP O
: : O O
ASA NNP B-NP O
, , I-NP O
CTX NNP I-NP O
1gm CC I-NP O
IV NNP I-NP O
, , O O
Azithromax NNP B-NP O
500mg CD I-NP O
po NN I-NP O
, , O O
Atrovent/Albuterol NNP B-NP O
nebs NNS I-NP O
. . O O
PMHx NNP B-NP O
: : O O
1 CD B-LST O
. . O O
HTN '' O O
2. . B-NP O
CAD NNP I-NP O
[old VBD B-VP O
MI NNP B-NP O
by IN B-PP O
EKG/imaging VBG B-VP O
] NNS B-NP O
3. CD B-NP O
COPD NN I-NP O
4 CD B-NP O
. . O O
Hypercholesterolemia NNP O O
5 CD B-NP O
. . O O
DM NNP B-NP O
, , O O
type NN B-NP O
II NNP I-NP O
6 CD B-NP O
. . O O
Recurrent NNP B-NP O
UTIs NNP I-NP O
[cystocele/recurrent NN I-NP O
UTI] . O O
7. . B-NP O
Chronic NNP I-NP O
LE JJ I-NP O
edema NN I-NP O
[ IN B-PP O
Doppler NNP B-NP O
NEG] . O O
8. . B-NP O
Anxiety NNP I-NP O
9 CD B-NP O
. . O O
GERD NNP O O
ALLERGIES NNS B-NP O
: : O O
Penicillin/Cephalosporins NNP B-NP O
- : O O
hives NNS B-NP O
MEDS NNS B-NP O
: : O O
Atenolol NNP B-NP O
100 CD I-NP O
mg NN I-NP O
PO NN I-NP O
qd . O O
Lipitor NNP B-NP O
10 CD I-NP O
mg NN I-NP O
po NN I-NP O
qd . O O
Cozaar NNP B-NP O
50 CD I-NP O
mg NN I-NP O
po NN I-NP O
qd . O O
Furosemide NNP B-NP O
20 CD I-NP O
mg NN I-NP O
po NN I-NP O
qde NN I-NP O
Prilosec NNP B-NP O
20 CD I-NP O
mg NN I-NP O
po NN I-NP O
qd . O O
ECASA NNP B-NP O
325 CD I-NP O
mg NN I-NP O
po NN I-NP O
qd . O O
Nifedipine NNP B-NP O
XL NNP I-NP O
60 CD I-NP O
mg NN I-NP O
po NN I-NP O
bid NN I-NP O
Klonazepam NNP B-NP O
0.5 CD I-NP O
mg JJ I-NP O
po NN I-NP O
bid NN I-NP O
SHx NNP B-NP O
: : O O
lives NNS B-NP O
alone RB B-ADVP O
, , O O
independent JJ B-ADJP O
with IN B-PP O
ADLs NNP B-NP O
PTA NNP I-NP O
FHx NNP B-NP O
: : O O
no DT B-NP O
CAD NN I-NP O
, , O O
DM NNP B-NP O
, , O O
stroke NN B-NP O
VS NNP B-NP O
: : O O
T NNP B-NP O
97 CD I-NP O
HR NNP I-NP O
84 CD I-NP O
BP NNP I-NP O
128/8 CD I-NP O
0 CD I-NP O
RR NNP I-NP O
22 CD I-NP O
Sat NNP I-NP O
97 CD I-NP O
% NN I-NP O
O2 . O O
HF . O O
PE NN B-NP O
: : O O
GEN NNS B-NP O
: : O O
slightly RB B-ADJP O
anxious JJ I-ADJP O
, , O O
with IN B-PP O
O2 DT B-NP O
mask NN I-NP O
on IN B-PP O
SKIN JJ B-NP O
: : O O
pale JJ B-NP O
, , O O
no DT B-NP O
ecchymoses NNS I-NP O
HEENT NNP B-NP O
: : O O
supple NN B-NP O
; : O O
JVP NNP B-NP O
~8cm NNP I-NP O
; : O O
no DT B-NP O
carotid NN I-NP O
bruits NNS I-NP O
CHEST NNP B-NP O
: : O O
bibasilar NN B-NP O
crackles NNS I-NP O
, , O O
few JJ B-NP O
scattered JJ I-NP O
wheezes NNS I-NP O
HEART NNP B-NP O
: : O O
RRR NN B-NP O
, , O O
( -LRB- B-NP O
+ NN I-NP O
) -RRB- I-NP O
2/6 CD I-NP O
SEM . O O
ABD NNP B-NP O
: : B-VP O
soft JJ B-ADJP O
, , O O
ND NNP B-NP O
, , O O
active JJ B-NP O
bowel NN I-NP O
sounds NNS I-NP O
EXT NNP B-NP O
: : O O
trace NN B-VP O
pitting NN B-NP O
edema NN I-NP O
bilat NN I-NP O
NEURO NNP B-NP O
: : O O
alert JJ B-NP O
, , I-NP O
appropriate JJ I-NP O
; : O O
CNs NNP B-NP O
intact JJ I-NP O
. . O O
Strength/sensation NNP O O
symmetric JJ B-ADJP O
. . O O
LABS NNP B-NP O
: : O O
Sodium NN B-NP O
( -LRB- I-NP O
Stat NNP I-NP O
Lab NNP I-NP O
) -RRB- I-NP O
132 CD I-NP O
L NNP B-NP O
135-145 CD I-NP O
mmol/L . O O
Potassium NNP B-NP O
( -LRB- I-NP O
Stat NN I-NP O
Lab NNP I-NP O
) -RRB- I-NP O
4.0 CD I-NP O
3.4-4.8 CD I-NP O
mmol/L . O O
Chloride NNP B-NP O
( -LRB- I-NP O
Stat NN I-NP O
Lab NN I-NP O
) -RRB- I-NP O
103 CD I-NP O
100-108 CD I-NP O
mmol/L . O O
CO2 NN B-NP O
( -LRB- I-NP O
Stat NNP I-NP O
Lab NNP I-NP O
) -RRB- I-NP O
19.8 CD I-NP O
L NNP B-NP O
24.0-30.0 CD I-NP O
mmol/L . O O
BUN NNP B-NP O
( -LRB- I-NP O
Stat NN I-NP O
Lab NN I-NP O
) -RRB- I-NP O
26 CD I-NP O
H NNP B-NP O
8-25 CD I-NP O
mg/dl . O O
Creatinine NNP B-NP O
( -LRB- I-NP O
Stat NN I-NP O
Lab NNP I-NP O
) -RRB- I-NP O
1.1 CD I-NP O
0.6-1.5 CD I-NP O
mg/dl . O O
Glucose FW B-NP O
( -LRB- I-NP O
Stat NN I-NP O
Lab NN I-NP O
) -RRB- I-NP O
262 CD I-NP O
H NNP B-NP O
70-110 CD I-NP O
mg/dl . O O
Calcium NNP B-NP O
9.0 CD I-NP O
8.5-10.5 CD I-NP O
mg/dl NN I-NP O
Phosphorus NNP B-NP O
3.9 CD I-NP O
2.6-4.5 CD I-NP O
mg/dl NN I-NP O
Magnesium NNP B-NP O
1.9 CD I-NP O
1.4-2.0 CD I-NP O
meq/L NNS I-NP O
Total JJ B-NP O
Protein NNP I-NP O
8.6 CD I-NP O
H NNP B-NP O
6.0-8.0 CD I-NP O
g/dl . O O
Albumin NNP B-NP O
3.6 CD I-NP O
3.1-4.3 CD I-NP O
g/dl NN I-NP O
Globulin NNP B-NP O
5.0 CD I-NP O
H NNP B-NP O
2.6-4.1 CD I-NP O
g/dl . O O
Direct JJ B-NP O
Bilirubin NNP I-NP O
0.0 CD I-NP O
0-0.4 CD I-NP O
mg/dl NN I-NP O
Total JJ B-NP O
Bilirubin NNP I-NP O
0.8 CD I-NP O
0-1.0 CD I-NP O
mg/dl NN I-NP O
Alkaline NNP B-NP O
Phosphatase NNP I-NP O
319 CD I-NP O
H NNP B-NP O
30-100 CD I-NP O
U/L . O O
Transaminase-SGPT NNP B-NP O
24 CD I-NP O
7-30 CD I-NP O
U/L . O O
Creatine JJ B-NP O
Kinase NNP I-NP O
Isoenzy NNP I-NP O
0.7 CD I-NP O
0.0-6.9 CD I-NP O
ng/ml NN I-NP O
Troponin-T NNP B-NP O
<0.01 CD I-NP O
0.00-0.09 CD I-NP O
ng/ml NN I-NP O
Transaminase-SGOT NNP B-NP O
60 CD I-NP O
H NNP B-NP O
9-25 CD I-NP O
U/L . O O
Creatine NNP B-NP O
Kinase NNP I-NP O
91 CD I-NP O
40-150 CD I-NP O
U/L . O O
WBC NNP B-NP O
11.9 CD I-NP O
H NNP B-NP O
4.5-11.0 CD I-NP O
th/cmm . O O
HCT NNP B-NP O
41.1 CD I-NP O
36.0-46.0 CD I-NP O
% NN I-NP O
HGB NNP B-NP O
13.9 CD I-NP O
12.0-16.0 CD I-NP O
gm/dl NN I-NP O
RBC NNP B-NP O
4.81 CD I-NP O
4.00-5.20 CD I-NP O
mil/cmm . O O
PLT NNP B-NP O
332 CD I-NP O
150-350 CD I-NP O
th/cumm . O O
MCV NNP B-NP O
86 CD I-NP O
80-100 CD I-NP O
fl NN I-NP O
MCH NNP B-NP O
28.8 CD I-NP O
26.0-34.0 CD I-NP O
pg/rbc NN I-NP O
MCHC NNP B-NP O
33.7 CD I-NP O
31.0-37.0 CD I-NP O
g/dl NN I-NP O
RDW NNP B-NP O
14.3 CD I-NP O
11.5-14.5 CD I-NP O
% NN I-NP O
Superstat NNP B-NP O
PT NNP I-NP O
12.4 CD I-NP O
11.1-13.1 CD I-NP O
sec NN I-NP O
Superstat NNP B-NP O
PT-INR NNP I-NP O
1.1 CD O O
Superstat NNP B-NP O
APTT NNP I-NP O
29.3 CD I-NP O
22.1-35.1 CD I-NP O
sec NN I-NP O
Poly NNP B-NP O
85 CD I-NP O
H NNP I-NP O
40-70 CD I-NP O
% NN I-NP O
Lymphs NNP B-NP O
11 CD I-NP O
L NNP I-NP O
22-44 CD I-NP O
% NN I-NP O
Monos NNP B-NP O
3 CD I-NP O
L NNP I-NP O
4-11 CD I-NP O
% NN I-NP O
EOS NNS B-NP O
1 CD B-NP O
0-8 CD I-NP O
% NN I-NP O
Basos NNS B-NP O
0 CD B-NP O
0-3 NN I-NP O
% NN I-NP O
Absolute JJ B-NP O
Neuts NNP I-NP O
10.05 CD I-NP O
H NNP B-NP O
1.8-7.7 CD I-NP O
th/cmm . O O
Absolute JJ B-NP O
Lymphs NNP I-NP O
1.33 CD I-NP O
1.0-4.8 CD I-NP O
th/cmm . O O
Absolute JJ B-NP O
Monos NNP I-NP O
0.40 CD I-NP O
0.2-0.4 CD I-NP O
th/cmm . O O
Absolute JJ B-NP O
EOS NNP I-NP O
0.10 CD I-NP O
0.1-0.3 CD I-NP O
th/cmm . O O
Absolute JJ B-NP O
Basos NNP I-NP O
0.04 CD I-NP O
0.0-0.3 CD I-NP O
th/cmm . O O
RBC NNP B-NP O
Morph NNP I-NP O
on IN B-PP O
Smear NNP B-NP O
NORMAL NNP I-NP O
NORMAL NNP I-NP O
EKG NN B-NP O
: : O O
old JJ B-NP O
LBBB NNP I-NP O
, , O O
no DT B-NP O
acute JJ I-NP O
ischemic JJ I-NP O
changes NNS I-NP O
CXR NN B-NP O
: : O O
cardiomegaly NN B-NP O
, , O O
bilateral JJ B-NP O
pleural JJ I-NP O
effusions NNS I-NP O
ADENOSINE NNP B-NP O
MIBI NNP I-NP O
( -LRB- I-NP O
6/89 CD I-NP B-DATE
) -RRB- I-NP O
: : O O
The DT B-NP O
ECG JJ I-NP O
response NN I-NP O
to TO B-PP O
pharmacological JJ B-NP O
stress NN I-NP O
was VBD B-VP O
negative JJ B-ADJP O
for IN B-PP O
ischemia NN B-NP O
. . O O
Images '' O O
demonstrated VBD B-VP O
a DT B-NP O
small JJ I-NP O
posterobasal NN I-NP O
infarction NN I-NP O
associated VBN B-VP O
with IN B-PP O
mild JJ B-ADJP O
to TO B-VP O
moderate VB I-VP O
inferior JJ B-NP O
ischemia NN I-NP O
. . B-NP O
Comparison NN I-NP O
to TO O O
2084 CD B-NP B-DATE
is VBZ B-VP O
difficult JJ B-ADJP O
due JJ I-ADJP O
to TO B-PP O
the DT B-NP O
difference NN I-NP O
of IN B-PP O
technique NN B-NP O
. . O O
However RB B-ADVP O
, , O O
septal JJ B-NP O
ischemia NN I-NP O
is VBZ B-VP O
no RB B-ADVP O
longer JJR B-NP O
present NN I-NP O
in IN B-PP O
the DT B-NP O
current JJ I-NP O
study NN I-NP O
and CC O O
inferior JJ B-NP O
ischemia NN I-NP O
is VBZ B-VP O
still RB B-ADVP O
present JJ B-ADJP O
. . O O
ECHO FW B-NP O
( -LRB- I-NP O
6/89 CD I-NP B-DATE
) -RRB- I-NP O
: : O O
mild JJ B-NP O
mitral JJ I-NP O
regurgitation NN I-NP O
; : O O
LA NNP B-NP O
dilated VBD B-VP O
; : O O
- : O O
trans-aortic JJ B-NP O
gradient JJ I-NP O
~13 NN I-NP O
mm CD I-NP O
HG/no NNP I-NP O
stenosis NN I-NP O
; : O O
- : O O
LV NN B-VP O
imildly RB I-VP O
dilated VBN I-VP O
, , O O
w/segmental JJ B-NP O
LV NNP I-NP O
dysfunction NN I-NP O
[inferior JJ I-NP O
wall NN I-NP O
] NNS I-NP O
; : O O
EF RB B-ADVP O
68 CD B-NP O
% NN I-NP O
; : O O
- : O O
trace NN B-VP O
tricuspid NN B-NP O
insufficiency NN I-NP O
- : O O
trace NN B-VP O
pulmonary NN B-NP O
insufficiency NN I-NP O
; : O O
RV NN B-NP O
34 CD B-NP O
mmHg/ NNS I-NP O
not RB B-VP O
dilated VBN I-VP O
A/P NNP B-NP O
: : O O
Pt NNP B-NP O
is VBZ B-VP O
a DT B-NP O
76 CD I-NP B-AGE
yo NNP I-NP O
F NNP I-NP O
with IN B-PP O
multiple JJ B-NP O
cardiac JJ I-NP O
risk NN I-NP O
factors NNS I-NP O
who WP B-NP O
presents VBZ B-VP O
with IN B-PP O
CHF NNP B-NP O
exacerbation NN I-NP O
. . O O
Ddx '' O O
of IN B-PP O
precipitants NNS B-NP O
include VBP B-VP O
new JJ B-NP O
myocardial JJ I-NP O
ischemia NN I-NP O
, , O O
hypertensive JJ B-NP O
crisis NN I-NP O
, , O O
medication NN B-NP O
non-compliance/misadministration NN I-NP O
, , O O
arrhythmia NN B-NP O
, , O O
or CC O O
infection NN B-NP O
. . O O
Even RB O O
though IN B-SBAR O
MI NNP B-NP O
would MD B-VP O
be VB I-VP O
the DT B-NP O
most RBS I-NP O
worrisome JJ I-NP O
to TO B-VP O
follow VB I-VP O
through IN B-PP O
with IN B-NP O
, , O O
a DT B-NP O
simple JJ I-NP O
trigger NN I-NP O
such JJ B-PP O
as IN I-PP O
COPD NNP B-NP O
exacerbation NN I-NP O
cannot MD B-VP O
be VB I-VP O
excluded VBN I-VP O
. . O O
- : O O
continue VBP B-VP O
HF IN B-PP O
O2 NNP B-NP O
, , O O
ASA NNP B-NP O
, , O O
cardiac JJ B-NP O
enzymes NNS I-NP O
to TO B-VP O
r/o VB I-VP O
MI NNP B-NP O
- : O O
tight JJ B-NP O
BP NNP I-NP O
control NN I-NP O
w/ IN B-PP O
CCB NNP B-NP O
and CC I-NP O
ACEI NNP I-NP O
as IN B-PP O
needed VBN B-NP O
; : O O
may MD B-VP O
use VB I-VP O
TNG/Hydralazine NN B-NP O
( -LRB- B-NP O
will MD B-VP O
hold VB I-VP O
BB NNP B-NP O
during IN B-PP O
the DT B-NP O
acute JJ I-NP O
exacerbation NN I-NP O
) -RRB- O O
- : B-NP O
Lasix NNP I-NP O
IV NNP I-NP O
prn NN I-NP O
; : O O
strict JJ B-NP O
I/Os NNS I-NP O
[admission IN B-PP O
wt JJ B-NP O
180# CD I-NP O
) -RRB- O O
- : O O
Low-sodium NN B-VP O
diet/consider NN B-NP O
fluid NN I-NP O
restriction NN I-NP O
- : O O
Repeat NN B-NP O
CXR/EKG NN I-NP O
- : O O
Azithromycin NNP B-NP O
250mg CD B-NP O
po/Albuterol/Atrovent NN I-NP O
nebs NNS I-NP O
- : O O
ECHO NNP B-NP O
in IN B-PP O
AM/consider NNP B-NP O
ETT/Cardiology NNP I-NP O
: : O O
Dr NNP B-NP O
Garner NNP I-NP B-DOCTOR
EVELYN NNP B-NP B-DOCTOR
HOLCOMB NNP I-NP I-DOCTOR
, , O O
M.D. NNP B-NP O
X NNP B-NP O
62950 CD I-NP B-PHONE
